FDA ANDA · ANDA218088

REVEFENACIN

Sponsor: LUPIN INC.

APPLICATION

ANDA218088

TYPE

ANDA

DOSAGE FORM

SOLUTION

MARKETING STATUS

None (Tentative Approval)

Products

REVEFENACINNone (Tentative Approval)

REVEFENACIN 88UG/3ML · SOLUTION

2026-05-15UNKNOWN · Original · standardTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.